Health experts, scholars call for more research on fasting by diabetics
Karachi
February 28, 2021
Despite the Covid-19 pandemic, hundreds of millions of Muslims around the globe fasted in Ramazan last year, and this year too an overwhelmingly large number of people wish to keep fasts, but those suffering from chronic illnesses like diabetes, hypertension and heart disease should consult their doctors and physicians for safe fasting and to reap the physical and spiritual benefits of fasting.
These observations were made by Islamic scholars and health experts at an international health conference on Saturday.
“There are some extreme views that fasting is very harmful for the diabetes patients in all circumstances, and there are some who say fasting should be practised [even] in worst [health] conditions, but I think medical practitioners will be in a better position to explain to the patients as to how they should fast safely,” renowned Islamic scholar Mufti Taqi Usmani said
Speakers stress need for people with chronic illnesses, comorbidities to consult doctors ahead of Ramazan
KARACHI:
There is need for more scientific research in the area of fasting with diabetes, emphasised health experts and religious scholars on Saturday, during a two-day online conference jointly organised by the Baqai Institute of Diabetology and Endocrinology, International Diabetes Federation (IDF) and other institutions.
Speaking on the first day of the ‘International Diabetes and Ramadan Conference, 2021’, the speakers stressed the need for persons having chronic illnesses, such as diabetes, hypertension and coronary diseases, to consult their doctors and physicians for ensuring safe fasting during Ramazan.
Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly s connected insulin solutions
News provided by
Share this article
(PRNewsfoto/Eli Lilly and Company)
COLUMBIA, Md. and INDIANAPOLIS, Feb. 25, 2021 /PRNewswire/ Welldoc, Inc., and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc s software into Lilly s connected insulin solutions, currently in development. Under the terms of the agreement, Lilly and Welldoc will collaborate to create a new version of the BlueStar
® insulin management solution that integrates insulin dosing data for several Lilly insulins. Lilly will commercialize the pen platform, which will include the new app and Lilly s connected insulin pen solutions.
Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
Search jobs 22-Feb-2021 Growing chronic disease prevalence will boost the maggot debridement market, forecast to touch US$ 15 Mn by 2025 at a CAGR of 10%
Noida, Uttar Pradesh, India, February 22 2021 (Wiredrelease) Report Ocean Pvt Ltd –:Global Maggot Debridement Market is estimated to see healthy growth, pegged at a CAGR of ~10% during the forecast period 2020-2025. The worldwide rise in the chronic disease incidence such as cancer, diabetes, and other autoimmune disorders significantly contributes to market growth. According to the National Diabetes Statistic (NDS) Report 2017, over 100 million US people live with diabetes or prediabetes published by the CDC. Furthermore, as per the International Diabetes Federation (IDF), the global prevalence of diabetes is likely to surge from 366 million in 2011 to 552 million by 2030. Since prolonged diabetes may lead to diabetic foot ulcers, the rising diabetes incidence is further expected